Stay updated on Oral Azacitidine + Venetoclax in Untreated MDS Clinical Trial
Sign up to get notified when there's something new on the Oral Azacitidine + Venetoclax in Untreated MDS Clinical Trial page.

Latest updates to the Oral Azacitidine + Venetoclax in Untreated MDS Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.3.3 was added to the Record History, and the footer now removes the HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check20 days agoChange DetectedThe study status changed from Recruiting to Active, not recruiting; new sections Contacts/Locations and Oversight were added as of 2025-12-03.SummaryDifference0.9%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedA new revision entry v3.3.2 was added to the Study Record Versions, and v3.2.0 was removed, reflecting metadata updates to the record history rather than changes to the trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedRemoved the nonessential government funding/operating-status banner from the page; core trial data and navigation remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check63 days agoChange DetectedVersion 8 (2025-05-16) adds updates to Study Identification and Study Status. Earlier versions included changes to Study Status, Recruitment Status, and Contacts/Locations.SummaryDifference0.1%

- Check91 days agoChange DetectedVersion bumped to v3.2.0 with an added government-operating-status notice; the previous v3.1.0 deletion indicates the page now reflects the updated version.SummaryDifference13%

Stay in the know with updates to Oral Azacitidine + Venetoclax in Untreated MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Azacitidine + Venetoclax in Untreated MDS Clinical Trial page.